Woodcock's future retirement will mark new era for FDA's drug center

10/10/2013 | Reuters

Some drugmakers are worried that the pace of drug approvals could slow after Janet Woodcock retires as director of the FDA's Center for Drug Evaluation and Research, according to this article. Woodcock is at least a year away from leaving that role. FDA divestment rules and other obstacles can make it hard to find a successor, she said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ